Fabrication of porous, drug-releasing, biodegradable, polymer scaffolds for sustained drug release
✍ Scribed by Mayur Uttarwar; Pranesh Aswath
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 930 KB
- Volume
- 87B
- Category
- Article
- ISSN
- 1552-4973
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Two different approaches were used to fabricate porous scaffolds, and their in vitro drug releasing characteristics were examined. In the first method, a poly(L‐lactic acid) (PLLA) solution and poly(vinyl alcohol) (PVA) + acetaminophen solution was homogenized. The emulsion was then blended with a PLLA solution in chloroform. The resultant emulsion was freeze‐dried to form porous scaffolds. Various combinations were obtained by varying homogenizer speed and blender speed, and by varying the concentration of PVA and acetaminophen solutions. The in vitro drug‐release study was performed for 6 days in a phosphate buffer. The influence of structure, porosity, and drug concentration of the scaffolds on drug‐release rate was examined using design of experiments. In the second approach, scaffolds were prepared in layered constructs, with either a three‐layered or five‐layered structure. The PVA + acetaminophen solution was blended with PLLA solution using a blender. The drug‐release study was performed for 19 days. The effect of drug concentration, blender speed, and the thickness of the layers on drug‐release rate was examined. © 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 2008
📜 SIMILAR VOLUMES
Poor drug encapsulation efficiency and rapid release of the encapsulated drug limit the use of nanoparticles in biomedical applications involving water-soluble drugs. We have developed a novel polymer-surfactant nanoparticle formulation, using the anionic surfactant Aerosol OT (AOT) and polysacchari
## Abstract In our previous studies we have reported on the development of diclofenac sodium (DS) releasing rods. However, their drug release profiles were unsatisfactory. To enhance the drug release properties of the implant, we have developed a system whereby various elements can be combined into
## Abstract Thermogelling emulsion system was developed to function as an embolic agent and sustained release system. PEG‐PLGA‐PEG triblock copolymer was synthesized, and blended with oily phase (Lipiodol®) to constitute the thermogelling emulsions. Because the polymer‐rich aqueous phase dramatical
## Abstract Heparin‐immobilized porous biodegradable scaffolds were fabricated to release basic fibroblast growth factor (bFGF) in a sustained manner. Heparin was covalently conjugated onto the surface of macroporous PLGA scaffolds fabricated by a gas‐foaming/salt‐leaching method. Sustained release